United Capital Financial Advisers Lowered Its Horizon Pharma Plc (HZNP) Stake; KT (KT) Shorts Lowered By 15.98%

December 14, 2017 - By Kurt Siggers

KT Corporation (NYSE:KT) had a decrease of 15.98% in short interest. KT’s SI was 2.44 million shares in December as released by FINRA. Its down 15.98% from 2.91M shares previously. With 1.07 million avg volume, 2 days are for KT Corporation (NYSE:KT)’s short sellers to cover KT’s short positions. The SI to KT Corporation’s float is 0.53%. The stock decreased 0.42% or $0.065 during the last trading session, reaching $15.385. About 184,603 shares traded. KT Corporation (NYSE:KT) has risen 15.78% since December 14, 2016 and is uptrending. It has underperformed by 0.92% the S&P500.

United Capital Financial Advisers Llc decreased Horizon Pharma Plc (HZNP) stake by 72.58% reported in 2017Q2 SEC filing. United Capital Financial Advisers Llc sold 97,952 shares as Horizon Pharma Plc (HZNP)’s stock declined 38.11%. The United Capital Financial Advisers Llc holds 37,009 shares with $439,000 value, down from 134,961 last quarter. Horizon Pharma Plc now has $2.46B valuation. The stock decreased 0.46% or $0.07 during the last trading session, reaching $15. About 460,877 shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since December 14, 2016 and is downtrending. It has underperformed by 44.83% the S&P500.

Investors sentiment increased to 1 in 2017 Q2. Its up 0.08, from 0.92 in 2017Q1. It improved, as 43 investors sold HZNP shares while 52 reduced holdings. 34 funds opened positions while 53 raised stakes. 130.94 million shares or 1.72% less from 133.24 million shares in 2017Q1 were reported. Moreover, Qs Investors Lc has 0.02% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Citadel Advisors holds 0.04% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 3.97M shares. Schwab Charles Mngmt accumulated 962,352 shares. Farallon Cap Management Llc reported 745,000 shares. Deerfield Management has 5.7% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 9.00 million shares. Globeflex Lp has invested 0.15% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Davidson Advisors reported 225 shares. Rmb Capital Mngmt Ltd Company invested in 100,033 shares. 18,315 were accumulated by American National Registered Advisor Inc. Dimensional Fund Advisors LP holds 0.03% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 6.27 million shares. Blackrock accumulated 0.01% or 13.50 million shares. Wfg Advisors Limited Partnership has 1 shares for 0% of their portfolio. Redwood Invs Ltd Liability Corporation reported 0.6% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Silvercrest Asset Management Gp Ltd invested 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Carroll Fincl Assocs Inc holds 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 700 shares.

United Capital Financial Advisers Llc increased Cyrusone Inc (NASDAQ:CONE) stake by 27,872 shares to 78,633 valued at $4.38 million in 2017Q2. It also upped International Business Machines Corp (NYSE:IBM) stake by 7,854 shares and now owns 208,547 shares. Coca (NYSE:KO) was raised too.

Analysts await Horizon Pharma Public Limited Company (NASDAQ:HZNP) to report earnings on February, 26. They expect $0.22 earnings per share, down 56.00% or $0.28 from last year’s $0.5 per share. HZNP’s profit will be $36.05 million for 17.05 P/E if the $0.22 EPS becomes a reality. After $0.26 actual earnings per share reported by Horizon Pharma Public Limited Company for the previous quarter, Wall Street now forecasts -15.38% negative EPS growth.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Horizon Pharma had 53 analyst reports since September 9, 2015 according to SRatingsIntel. On Tuesday, May 9 the stock rating was downgraded by Mizuho to “Neutral”. Jefferies reinitiated the stock with “Buy” rating in Monday, November 23 report. UBS maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Thursday, November 30. UBS has “Buy” rating and $20.0 target. Mizuho maintained the stock with “Hold” rating in Monday, August 28 report. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by Mizuho on Tuesday, May 3. On Friday, December 9 the stock rating was downgraded by Mizuho to “Neutral”. The firm has “Hold” rating given on Monday, August 7 by Mizuho. BMO Capital Markets maintained it with “Buy” rating and $18.0 target in Tuesday, September 26 report. The rating was initiated by Jefferies with “Buy” on Tuesday, January 19. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by Stifel Nicolaus on Tuesday, June 27.

KT Corporation provides telecommunications services in Korea. The company has market cap of $6.59 billion. The firm offers fixed-line telephone services, including local, domestic long-distance, and international long-distance fixed-line and voice over Internet protocol telephone services, as well as interconnection services; Internet phone services; broadband Internet access and other Internet-related services, including Internet protocol television services; and data communication services, including leased line and dedicated broadband Internet connection services to institutional customers. It has a 11.51 P/E ratio. It also provides mobile voice and data telecommunications services; and credit card processing and other financial services, as well as sells mobile handsets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: